Riki Stevenson

Title: Riki Stevenson: Innovator in Antigen Binding Proteins

Introduction

Riki Stevenson is a notable inventor based in Ventura, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of low-viscosity antigen binding proteins. With a total of 3 patents, his work is paving the way for advancements in therapeutic applications.

Latest Patents

Stevenson's latest patents focus on methods for preparing antigen binding proteins with reduced viscosity. The first patent details a method for creating antigen binding proteins specific for PCSK9 by replacing residues in high viscosity variable domain subfamilies with those in correlating low viscosity subfamilies. Additionally, it involves substituting residues in the Fc domain with those associated with low viscosity and adding charged residues to the C-terminus of the Fc domain. The second patent mirrors this approach, emphasizing the importance of these modifications in producing effective antigen binding proteins.

Career Highlights

Riki Stevenson is currently employed at Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on innovative solutions that address critical health challenges. His expertise in protein engineering has positioned him as a valuable asset in the field.

Collaborations

Stevenson has collaborated with notable colleagues, including Joon Hoi Huh and Pavel V Bondarenko. These partnerships have fostered a collaborative environment that enhances the research and development of new biotechnological solutions.

Conclusion

Riki Stevenson is a prominent figure in the field of biotechnology, with a focus on low-viscosity antigen binding proteins. His innovative patents and contributions at Amgen Inc. highlight his commitment to advancing medical science. His work continues to inspire future developments in the industry.